Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Progress in the use of biochemical and biological markers for evaluation of rheumatoid arthritis

1 Jan 2000

Abstract excerpt

Rheumatoid arthritis (RA) is a chronic systemic inflammatory autoimmune disorder which is predominant in females. The exact etiology remains undefined. Recently, a large number of biochemical and biologic markers, which are useful in the diagnosis, prognosis, and monitoring therapy of RA, have been reported. The new markers include genetic markers, filaggrin, citrulline containing peptides, A2/RA33, cytokines,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoimmune and Inflammatory Disorders Research
Share to Rheumatoid Arthritis Research and Therapies
Share to Viral Infections and Immunology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 11138614
DOI: 10.1002/1098-2825(20001212)14:6<305::aid-jcla10>3.0.co;2-p

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Progress in the use of biochemical and biological markers for evaluation of rheumatoid arthritisPMID 11138614Read ↗

The evolution of biomarkers in rheumatoid arthritis: from clinical research to clinical care.Semantic proximity Read ↗

Biomarkers for rheumatoid arthritis: From molecular processes to diagnostic applications-current concepts and future perspectivesSemantic proximity Read ↗

The Clinical Value of Autoantibodies in Rheumatoid ArthritisSemantic proximity Read ↗

Autoantibodies to citrullinated proteins in rheumatoid arthritis: clinical performance and biochemical aspects of an RA-specific markerSemantic proximity Read ↗

Clinical Phenotypes, Serological Biomarkers, and Synovial Features Defining Seropositive and Seronegative Rheumatoid Arthritis: A Literature Review.Semantic proximity Read ↗

The roles of anti-citrullinated protein antibodies in the immunopathogenesis of rheumatoid arthritisSemantic proximity Read ↗

Prevention and cure: The major unmet needs in the management of rheumatoid arthritis.Semantic proximity Read ↗

Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and PharmacogeneticsSemantic proximity Read ↗

Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritisSemantic proximity Read ↗

Development of a Novel Diagnostic Biomarker Set for Rheumatoid Arthritis Using a Proteomics ApproachSemantic proximity Read ↗

The ongoing quest for biomarkers in Ankylosing Spondylitis.Semantic proximity Read ↗

Prediction of functional impairment and remission in rheumatoid arthritis patients by biochemical variables and genetic polymorphisms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.